関連する実験動画

Updated: Feb 17, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

11.1K

制限された平均生存時間を用いて進行性尿路がんの治療法を再評価する: 系統的レビューとネットワークメタ解析

Shugo Yajima1, Wei Chen2, Kohei Hirose1

  • 1Department of Urology, National Cancer Center Hospital East, Chiba, Japan.

European urology open science
|February 16, 2026
PubMed
まとめ

従来の統計的方法では,遅延した効果のために,免疫チェックポイント阻害剤 (ICI) 試験結果が曖昧になることがあります. 制限平均生存時間 (RMST) 分析は,早期のICIの害を明らかにし,益を定量化し,免疫療法試験におけるその使用を支持しています.

キーワード:
免疫チェックポイント阻害剤ネットワークメタ分析比例する危険性制限された平均生存時間.泌尿器官がん (Urotelial carcinoma) とは,泌尿器官がん (Urotelial carcinoma) とは,泌尿器官がん (Urotelial carcinoma) とは,泌尿器官がん (Urotelial carcinoma) とは,泌尿器官がん (Urotelial carcinoma) とは,泌尿器官がん (Urotelial carcinoma) とは,泌尿器官がん (Urotelial carcinoma) とは,

さらに関連する動画

Technical Modification of the Terminal Ureter During Total Transperitoneal Laparoscopic Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma06:39

Technical Modification of the Terminal Ureter During Total Transperitoneal Laparoscopic Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma

Published on: November 22, 2019

8.3K
A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

889

関連する概念動画

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
784
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
634
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
621
Actuarial Approach01:20

Actuarial Approach

The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
325